Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review

Author:

Kodeboina Monika123,Piayda Kerstin45ORCID,Jenniskens Inge6,Vyas Pearl6,Chen Sara7,Pesigan Ramon Julian6,Ferko Nicole8,Patel Barkha P.8ORCID,Dobrin Annamaria8,Habib Jayson8ORCID,Franke Jennifer49

Affiliation:

1. Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium

2. Department of Advanced Biomedical Sciences, University of Naples Federico II, 80138 Naples, Italy

3. Clinic for Internal Medicine and Cardiology, Marien Hospital, 52066 Aachen, Germany

4. Cardiovascular Center Frankfurt, 60389 Frankfurt, Germany

5. Department of Cardiology and Vascular Medicine, Medical Faculty, Justus-Liebig-University Giessen, 35392 Giessen, Germany

6. Philips, 5684 PC Best, The Netherlands

7. Philips, San Diego, CA 92130, USA

8. EVERSANA, Burlington, ON L7N 3H8, Canada

9. Philips Chief Medical Office, 22335 Hamburg, Germany

Abstract

Clinical and economic burdens exist within the coronary artery disease (CAD) care pathway despite advances in diagnosis and treatment and the increasing utilization of percutaneous coronary intervention (PCI). However, research presenting a comprehensive assessment of the challenges across this pathway is scarce. This contemporary review identifies relevant studies related to inefficiencies in the diagnosis, treatment, and management of CAD, including clinician, patient, and economic burdens. Studies demonstrating the benefits of integration and automation within the catheterization laboratory and across the CAD care pathway were also included. Most studies were published in the last 5–10 years and focused on North America and Europe. The review demonstrated multiple potentially avoidable inefficiencies, with a focus on access, appropriate use, conduct, and follow-up related to PCI. Inefficiencies included misdiagnosis, delays in emergency care, suboptimal testing, longer procedure times, risk of recurrent cardiac events, incomplete treatment, and challenges accessing and adhering to post-acute care. Across the CAD pathway, this review revealed that high clinician burnout, complex technologies, radiation, and contrast media exposure, amongst others, negatively impact workflow and patient care. Potential solutions include greater integration and interoperability between technologies and systems, improved standardization, and increased automation to reduce burdens in CAD and improve patient outcomes.

Funder

Philips

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference203 articles.

1. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study;Khan;Cureus,2020

2. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015;Roth;J. Am. Coll. Cardiol.,2017

3. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association;Tsao;Circulation,2023

4. Institute for Health Metrics and Evaluation (2022, July 20). Global Burden of Disease (GBD) Results Tool. Available online: https://ghdx.healthdata.org/gbd-results-tool.

5. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: Results from the Global Burden of Disease Study 2017;Dai;Eur. Heart J. Qual. Care Clin. Outcomes,2022

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3